Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global Muscle-on-a-Chip Market Research Report 2026
Global Muscle-on-a-Chip Market Research Report 2026
Industry: Medical Devices & Consumables
Published Date: 2026-01-15
Pages: 124 Pages
Report ld: 5683662
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
Muscle-on-a-Chip Market Size(US$)
CAGR 2026-2032
26.1%
Market Size,2032
USD 1,784
Million
Market Snapshot
Market Size in 2026 (Value)
US$ 444 million
Market Forecast in 2032(Value)
US$ 1,784 million
CAGR
26.1%
Years Considered
2021-2032
Base Year
2026
Forecast Period
2026-2032
Source: Secondary research, interviews with experts, and QYResearch analysis
The global Muscle-on-a-Chip market was valued at US$ 359 million in 2025 and is anticipated to reach US$ 1784 million by 2032, at a CAGR of 26.1% from 2026 to 2032.
The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Muscle-on-a-Chip competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
As an emerging market segment in the biomedical field, the muscle chip market has gradually attracted widespread attention from the industry in recent years. Muscle chips can simulate the structure and function of muscle tissue, providing a powerful tool for the research of muscle-related diseases, drug development and personalized medicine. Muscle chips have broad application potential in multiple fields, including diagnosis of muscle diseases, drug screening, toxicity testing, sports rehabilitation, and personalized medicine. By simulating the physiological and pathological processes of muscle tissue, muscle chips can help researchers gain a deeper understanding of the pathogenesis of muscle diseases, accelerate drug development, and improve treatment effects. Overall, the muscle chip market has broad development prospects and huge market potential.
This report delivers a comprehensive overview of the global Muscle-on-a-Chip market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Muscle-on-a-Chip. The Muscle-on-a-Chip market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Muscle-on-a-Chip market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Muscle-on-a-Chip manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
MARKET SEGMENTATION
By Company
- Emulate
- CN Bio
- TissUse
- Axion Biosystems
- Nortis
- BioIVT
- InSphero
- Mimetas
- Ascendance Biotechnology
- StemoniX
- Tara Biosystems
- BGI Genomics
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Skeletal Muscle
- Smooth Muscle
- Other
Segment by Application
- Pharmaceutical R&D
- Sports Medicine
- Sports Equipment Development
CHAPTER OUTLINE
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Provides a detailed analysis of the competitive landscape for Muscle-on-a-Chip manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
Chapter 3: Examines Muscle-on-a-Chip sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
Chapter 9: Summarizes the key findings and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Muscle-on-a-Chip Market Overview
1.1 Product Definition
1.2 Muscle-on-a-Chip by Type
1.2.1 Global Muscle-on-a-Chip Market Value by Type: 2025 vs 2032
1.2.2 Skeletal Muscle
1.2.3 Smooth Muscle
1.2.4 Other
1.3 Muscle-on-a-Chip by Application
1.3.1 Global Muscle-on-a-Chip Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceutical R&D
1.3.3 Sports Medicine
1.3.4 Sports Equipment Development
1.4 Global Muscle-on-a-Chip Market Size Estimates and Forecasts
1.4.1 Global Muscle-on-a-Chip Revenue 2021–2032
1.4.2 Global Muscle-on-a-Chip Sales 2021–2032
1.4.3 Global Muscle-on-a-Chip Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Muscle-on-a-Chip Market Competition by Manufacturers
2.1 Global Muscle-on-a-Chip Sales Market Share by Manufacturers (2021–2026)
2.2 Global Muscle-on-a-Chip Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Muscle-on-a-Chip Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Muscle-on-a-Chip, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Muscle-on-a-Chip, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Muscle-on-a-Chip, Product Types and Applications
2.7 Global Key Manufacturers of Muscle-on-a-Chip, Date of Entry into the Industry
2.8 Global Muscle-on-a-Chip Market Competitive Situation and Trends
2.8.1 Global Muscle-on-a-Chip Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Muscle-on-a-Chip Players Market Share by Revenue
2.8.3 Global Muscle-on-a-Chip Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Muscle-on-a-Chip Market Scenario by Region
3.1 Global Muscle-on-a-Chip Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Muscle-on-a-Chip Sales by Region: 2021–2032
3.2.1 Global Muscle-on-a-Chip Sales by Region: 2021–2026
3.2.2 Global Muscle-on-a-Chip Sales by Region: 2027–2032
3.3 Global Muscle-on-a-Chip Revenue by Region: 2021–2032
3.3.1 Global Muscle-on-a-Chip Revenue by Region: 2021–2026
3.3.2 Global Muscle-on-a-Chip Revenue by Region: 2027–2032
3.4 North America Muscle-on-a-Chip Market Facts & Figures by Country
3.4.1 North America Muscle-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Muscle-on-a-Chip Sales by Country (2021–2032)
3.4.3 North America Muscle-on-a-Chip Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Muscle-on-a-Chip Market Facts & Figures by Country
3.5.1 Europe Muscle-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Muscle-on-a-Chip Sales by Country (2021–2032)
3.5.3 Europe Muscle-on-a-Chip Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Muscle-on-a-Chip Market Facts & Figures by Region
3.6.1 Asia Pacific Muscle-on-a-Chip Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Muscle-on-a-Chip Sales by Region (2021–2032)
3.6.3 Asia Pacific Muscle-on-a-Chip Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Muscle-on-a-Chip Market Facts & Figures by Country
3.7.1 Latin America Muscle-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Muscle-on-a-Chip Sales by Country (2021–2032)
3.7.3 Latin America Muscle-on-a-Chip Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Muscle-on-a-Chip Market Facts & Figures by Country
3.8.1 Middle East and Africa Muscle-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Muscle-on-a-Chip Sales by Country (2021–2032)
3.8.3 Middle East and Africa Muscle-on-a-Chip Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Muscle-on-a-Chip Sales by Type (2021–2032)
4.1.1 Global Muscle-on-a-Chip Sales by Type (2021–2026)
4.1.2 Global Muscle-on-a-Chip Sales by Type (2027–2032)
4.1.3 Global Muscle-on-a-Chip Sales Market Share by Type (2021–2032)
4.2 Global Muscle-on-a-Chip Revenue by Type (2021–2032)
4.2.1 Global Muscle-on-a-Chip Revenue by Type (2021–2026)
4.2.2 Global Muscle-on-a-Chip Revenue by Type (2027–2032)
4.2.3 Global Muscle-on-a-Chip Revenue Market Share by Type (2021–2032)
4.3 Global Muscle-on-a-Chip Price by Type (2021–2032)
5 Segment by Application
5.1 Global Muscle-on-a-Chip Sales by Application (2021–2032)
5.1.1 Global Muscle-on-a-Chip Sales by Application (2021–2026)
5.1.2 Global Muscle-on-a-Chip Sales by Application (2027–2032)
5.1.3 Global Muscle-on-a-Chip Sales Market Share by Application (2021–2032)
5.2 Global Muscle-on-a-Chip Revenue by Application (2021–2032)
5.2.1 Global Muscle-on-a-Chip Revenue by Application (2021–2026)
5.2.2 Global Muscle-on-a-Chip Revenue by Application (2027–2032)
5.2.3 Global Muscle-on-a-Chip Revenue Market Share by Application (2021–2032)
5.3 Global Muscle-on-a-Chip Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Company Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Emulate Muscle-on-a-Chip Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 CN Bio
6.2.1 CN Bio Company Information
6.2.2 CN Bio Description and Business Overview
6.2.3 CN Bio Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CN Bio Muscle-on-a-Chip Product Portfolio
6.2.5 CN Bio Recent Developments/Updates
6.3 TissUse
6.3.1 TissUse Company Information
6.3.2 TissUse Description and Business Overview
6.3.3 TissUse Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TissUse Muscle-on-a-Chip Product Portfolio
6.3.5 TissUse Recent Developments/Updates
6.4 Axion Biosystems
6.4.1 Axion Biosystems Company Information
6.4.2 Axion Biosystems Description and Business Overview
6.4.3 Axion Biosystems Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Axion Biosystems Muscle-on-a-Chip Product Portfolio
6.4.5 Axion Biosystems Recent Developments/Updates
6.5 Nortis
6.5.1 Nortis Company Information
6.5.2 Nortis Description and Business Overview
6.5.3 Nortis Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nortis Muscle-on-a-Chip Product Portfolio
6.5.5 Nortis Recent Developments/Updates
6.6 BioIVT
6.6.1 BioIVT Company Information
6.6.2 BioIVT Description and Business Overview
6.6.3 BioIVT Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BioIVT Muscle-on-a-Chip Product Portfolio
6.6.5 BioIVT Recent Developments/Updates
6.7 InSphero
6.7.1 InSphero Company Information
6.7.2 InSphero Description and Business Overview
6.7.3 InSphero Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 InSphero Muscle-on-a-Chip Product Portfolio
6.7.5 InSphero Recent Developments/Updates
6.8 Mimetas
6.8.1 Mimetas Company Information
6.8.2 Mimetas Description and Business Overview
6.8.3 Mimetas Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Mimetas Muscle-on-a-Chip Product Portfolio
6.8.5 Mimetas Recent Developments/Updates
6.9 Ascendance Biotechnology
6.9.1 Ascendance Biotechnology Company Information
6.9.2 Ascendance Biotechnology Description and Business Overview
6.9.3 Ascendance Biotechnology Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Ascendance Biotechnology Muscle-on-a-Chip Product Portfolio
6.9.5 Ascendance Biotechnology Recent Developments/Updates
6.10 StemoniX
6.10.1 StemoniX Company Information
6.10.2 StemoniX Description and Business Overview
6.10.3 StemoniX Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 StemoniX Muscle-on-a-Chip Product Portfolio
6.10.5 StemoniX Recent Developments/Updates
6.11 Tara Biosystems
6.11.1 Tara Biosystems Company Information
6.11.2 Tara Biosystems Description and Business Overview
6.11.3 Tara Biosystems Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Tara Biosystems Muscle-on-a-Chip Product Portfolio
6.11.5 Tara Biosystems Recent Developments/Updates
6.12 BGI Genomics
6.12.1 BGI Genomics Company Information
6.12.2 BGI Genomics Description and Business Overview
6.12.3 BGI Genomics Muscle-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 BGI Genomics Muscle-on-a-Chip Product Portfolio
6.12.5 BGI Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Muscle-on-a-Chip Industry Chain Analysis
7.2 Muscle-on-a-Chip Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Muscle-on-a-Chip Production Mode & Process Analysis
7.4 Muscle-on-a-Chip Sales and Marketing
7.4.1 Muscle-on-a-Chip Sales Channels
7.4.2 Muscle-on-a-Chip Distributors
7.5 Muscle-on-a-Chip Customer Analysis
8 Muscle-on-a-Chip Market Dynamics
8.1 Muscle-on-a-Chip Industry Trends
8.2 Muscle-on-a-Chip Market Drivers
8.3 Muscle-on-a-Chip Market Challenges
8.4 Muscle-on-a-Chip Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
Table 1. Global Muscle-on-a-Chip Market Value by Type (US$ Million), 2025 vs 2032
Table 2. Global Muscle-on-a-Chip Market Value by Application (US$ Million), 2025 vs 2032
Table 3. Global Muscle-on-a-Chip Market Competitive Situation by Manufacturers in 2025
Table 4. Global Muscle-on-a-Chip Sales (K Units) of Key Manufacturers (2021–2026)
Table 5. Global Muscle-on-a-Chip Sales Market Share by Manufacturers (2021–2026)
Table 6. Global Muscle-on-a-Chip Revenue (US$ Million) by Manufacturers (2021–2026)
Table 7. Global Muscle-on-a-Chip Revenue Share by Manufacturers (2021–2026)
Table 8. Global Market Muscle-on-a-Chip Average Price (US$/Unit) of Key Manufacturers (2021–2026)
Table 9. Global Key Players of Muscle-on-a-Chip, Industry Ranking, 2023 vs 2024 vs 2025
Table 10. Global Key Manufacturers of Muscle-on-a-Chip, Manufacturing Sites and Headquarters
Table 11. Global Key Manufacturers of Muscle-on-a-Chip, Product Types and Applications
Table 12. Global Key Manufacturers of Muscle-on-a-Chip, Date of Entry into the Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Muscle-on-a-Chip Companies by Tier (Tier 1, Tier 2, Tier 3), based on Muscle-on-a-Chip Revenue, 2025
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Muscle-on-a-Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 17. Global Muscle-on-a-Chip Sales by Region (K Units), 2021–2026
Table 18. Global Muscle-on-a-Chip Sales Market Share by Region (2021–2026)
Table 19. Global Muscle-on-a-Chip Sales by Region (K Units), 2027–2032
Table 20. Global Muscle-on-a-Chip Sales Market Share by Region (2027–2032)
Table 21. Global Muscle-on-a-Chip Revenue by Region (US$ Million), 2021–2026
Table 22. Global Muscle-on-a-Chip Revenue Market Share by Region (2021–2026)
Table 23. Global Muscle-on-a-Chip Revenue by Region (US$ Million), 2027–2032
Table 24. Global Muscle-on-a-Chip Revenue Market Share by Region (2027–2032)
Table 25. North America Muscle-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 26. North America Muscle-on-a-Chip Sales by Country (K Units), 2021–2026
Table 27. North America Muscle-on-a-Chip Sales by Country (K Units), 2027–2032
Table 28. North America Muscle-on-a-Chip Revenue by Country (US$ Million), 2021–2026
Table 29. North America Muscle-on-a-Chip Revenue by Country (US$ Million), 2027–2032
Table 30. Europe Muscle-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 31. Europe Muscle-on-a-Chip Sales by Country (K Units), 2021–2026
Table 32. Europe Muscle-on-a-Chip Sales by Country (K Units), 2027–2032
Table 33. Europe Muscle-on-a-Chip Revenue by Country (US$ Million), 2021–2026
Table 34. Europe Muscle-on-a-Chip Revenue by Country (US$ Million), 2027–2032
Table 35. Asia Pacific Muscle-on-a-Chip Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
Table 36. Asia Pacific Muscle-on-a-Chip Sales by Region (K Units), 2021–2026
Table 37. Asia Pacific Muscle-on-a-Chip Sales by Region (K Units), 2027–2032
Table 38. Asia Pacific Muscle-on-a-Chip Revenue by Region (US$ Million), 2021–2026
Table 39. Asia Pacific Muscle-on-a-Chip Revenue by Region (US$ Million), 2027–2032
Table 40. Latin America Muscle-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 41. Latin America Muscle-on-a-Chip Sales by Country (K Units), 2021–2026
Table 42. Latin America Muscle-on-a-Chip Sales by Country (K Units), 2027–2032
Table 43. Latin America Muscle-on-a-Chip Revenue by Country (US$ Million), 2021–2026
Table 44. Latin America Muscle-on-a-Chip Revenue by Country (US$ Million), 2027–2032
Table 45. Middle East and Africa Muscle-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
Table 46. Middle East and Africa Muscle-on-a-Chip Sales by Country (K Units), 2021–2026
Table 47. Middle East and Africa Muscle-on-a-Chip Sales by Country (K Units), 2027–2032
Table 48. Middle East and Africa Muscle-on-a-Chip Revenue by Country (US$ Million), 2021–2026
Table 49. Middle East and Africa Muscle-on-a-Chip Revenue by Country (US$ Million), 2027–2032
Table 50. Global Muscle-on-a-Chip Sales (K Units) by Type (2021–2026)
Table 51. Global Muscle-on-a-Chip Sales (K Units) by Type (2027–2032)
Table 52. Global Muscle-on-a-Chip Sales Market Share by Type (2021–2026)
Table 53. Global Muscle-on-a-Chip Sales Market Share by Type (2027–2032)
Table 54. Global Muscle-on-a-Chip Revenue (US$ Million) by Type (2021–2026)
Table 55. Global Muscle-on-a-Chip Revenue (US$ Million) by Type (2027–2032)
Table 56. Global Muscle-on-a-Chip Revenue Market Share by Type (2021–2026)
Table 57. Global Muscle-on-a-Chip Revenue Market Share by Type (2027–2032)
Table 58. Global Muscle-on-a-Chip Price (US$/Unit) by Type (2021–2026)
Table 59. Global Muscle-on-a-Chip Price (US$/Unit) by Type (2027–2032)
Table 60. Global Muscle-on-a-Chip Sales (K Units) by Application (2021–2026)
Table 61. Global Muscle-on-a-Chip Sales (K Units) by Application (2027–2032)
Table 62. Global Muscle-on-a-Chip Sales Market Share by Application (2021–2026)
Table 63. Global Muscle-on-a-Chip Sales Market Share by Application (2027–2032)
Table 64. Global Muscle-on-a-Chip Revenue (US$ Million) by Application (2021–2026)
Table 65. Global Muscle-on-a-Chip Revenue (US$ Million) by Application (2027–2032)
Table 66. Global Muscle-on-a-Chip Revenue Market Share by Application (2021–2026)
Table 67. Global Muscle-on-a-Chip Revenue Market Share by Application (2027–2032)
Table 68. Global Muscle-on-a-Chip Price (US$/Unit) by Application (2021–2026)
Table 69. Global Muscle-on-a-Chip Price (US$/Unit) by Application (2027–2032)
Table 70. Emulate Company Information
Table 71. Emulate Description and Business Overview
Table 72. Emulate Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 73. Emulate Muscle-on-a-Chip Product
Table 74. Emulate Recent Developments/Updates
Table 75. CN Bio Company Information
Table 76. CN Bio Description and Business Overview
Table 77. CN Bio Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 78. CN Bio Muscle-on-a-Chip Product
Table 79. CN Bio Recent Developments/Updates
Table 80. TissUse Company Information
Table 81. TissUse Description and Business Overview
Table 82. TissUse Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 83. TissUse Muscle-on-a-Chip Product
Table 84. TissUse Recent Developments/Updates
Table 85. Axion Biosystems Company Information
Table 86. Axion Biosystems Description and Business Overview
Table 87. Axion Biosystems Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 88. Axion Biosystems Muscle-on-a-Chip Product
Table 89. Axion Biosystems Recent Developments/Updates
Table 90. Nortis Company Information
Table 91. Nortis Description and Business Overview
Table 92. Nortis Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 93. Nortis Muscle-on-a-Chip Product
Table 94. Nortis Recent Developments/Updates
Table 95. BioIVT Company Information
Table 96. BioIVT Description and Business Overview
Table 97. BioIVT Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 98. BioIVT Muscle-on-a-Chip Product
Table 99. BioIVT Recent Developments/Updates
Table 100. InSphero Company Information
Table 101. InSphero Description and Business Overview
Table 102. InSphero Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 103. InSphero Muscle-on-a-Chip Product
Table 104. InSphero Recent Developments/Updates
Table 105. Mimetas Company Information
Table 106. Mimetas Description and Business Overview
Table 107. Mimetas Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 108. Mimetas Muscle-on-a-Chip Product
Table 109. Mimetas Recent Developments/Updates
Table 110. Ascendance Biotechnology Company Information
Table 111. Ascendance Biotechnology Description and Business Overview
Table 112. Ascendance Biotechnology Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 113. Ascendance Biotechnology Muscle-on-a-Chip Product
Table 114. Ascendance Biotechnology Recent Developments/Updates
Table 115. StemoniX Company Information
Table 116. StemoniX Description and Business Overview
Table 117. StemoniX Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 118. StemoniX Muscle-on-a-Chip Product
Table 119. StemoniX Recent Developments/Updates
Table 120. Tara Biosystems Company Information
Table 121. Tara Biosystems Description and Business Overview
Table 122. Tara Biosystems Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 123. Tara Biosystems Muscle-on-a-Chip Product
Table 124. Tara Biosystems Recent Developments/Updates
Table 125. BGI Genomics Company Information
Table 126. BGI Genomics Description and Business Overview
Table 127. BGI Genomics Muscle-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
Table 128. BGI Genomics Muscle-on-a-Chip Product
Table 129. BGI Genomics Recent Developments/Updates
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Muscle-on-a-Chip Distributors List
Table 133. Muscle-on-a-Chip Customers List
Table 134. Muscle-on-a-Chip Market Trends
Table 135. Muscle-on-a-Chip Market Drivers
Table 136. Muscle-on-a-Chip Market Challenges
Table 137. Muscle-on-a-Chip Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
Table 141. Authors List of This Report
List of Figures
Figure 1. Product Picture of Muscle-on-a-Chip
Figure 2. Global Muscle-on-a-Chip Market Value by Type (US$ Million), 2021–2032
Figure 3. Global Muscle-on-a-Chip Market Share by Type: 2025 & 2032
Figure 4. Skeletal Muscle Product Picture
Figure 5. Smooth Muscle Product Picture
Figure 6. Other Product Picture
Figure 7. Global Muscle-on-a-Chip Market Value by Application (US$ Million), 2021–2032
Figure 8. Global Muscle-on-a-Chip Market Share by Application: 2025 & 2032
Figure 9. Pharmaceutical R&D
Figure 10. Sports Medicine
Figure 11. Sports Equipment Development
Figure 12. Global Muscle-on-a-Chip Revenue, (US$ Million), 2021 vs 2025 vs 2032
Figure 13. Global Muscle-on-a-Chip Market Size (US$ Million), 2021–2032
Figure 14. Global Muscle-on-a-Chip Sales (K Units), 2021–2032
Figure 15. Global Muscle-on-a-Chip Average Price (US$/Unit), 2021–2032
Figure 16. Muscle-on-a-Chip Report Years Considered
Figure 17. Muscle-on-a-Chip Sales Share by Manufacturers in 2025
Figure 18. Global Muscle-on-a-Chip Revenue Share by Manufacturers in 2025
Figure 19. Top 5 and Top 10 Global Muscle-on-a-Chip Players: Market Share by Revenue in Muscle-on-a-Chip in 2025
Figure 20. Muscle-on-a-Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
Figure 21. Global Muscle-on-a-Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Figure 22. North America Muscle-on-a-Chip Sales Market Share by Country (2021–2032)
Figure 23. North America Muscle-on-a-Chip Revenue Market Share by Country (2021–2032)
Figure 24. United States Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 25. Canada Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 26. Europe Muscle-on-a-Chip Sales Market Share by Country (2021–2032)
Figure 27. Europe Muscle-on-a-Chip Revenue Market Share by Country (2021–2032)
Figure 28. Germany Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 29. France Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 30. U.K. Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 31. Italy Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 32. Russia Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 33. Asia Pacific Muscle-on-a-Chip Sales Market Share by Region (2021–2032)
Figure 34. Asia Pacific Muscle-on-a-Chip Revenue Market Share by Region (2021–2032)
Figure 35. China Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 36. Japan Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 37. South Korea Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 38. India Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 39. Australia Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 40. China Taiwan Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 41. Southeast Asia Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 42. Latin America Muscle-on-a-Chip Sales Market Share by Country (2021–2032)
Figure 43. Latin America Muscle-on-a-Chip Revenue Market Share by Country (2021–2032)
Figure 44. Mexico Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 45. Brazil Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 46. Argentina Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 47. Colombia Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 48. Middle East and Africa Muscle-on-a-Chip Sales Market Share by Country (2021–2032)
Figure 49. Middle East and Africa Muscle-on-a-Chip Revenue Market Share by Country (2021–2032)
Figure 50. Turkey Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 51. Saudi Arabia Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 52. UAE Muscle-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
Figure 53. Global Sales Market Share of Muscle-on-a-Chip by Type (2021–2032)
Figure 54. Global Revenue Market Share of Muscle-on-a-Chip by Type (2021–2032)
Figure 55. Global Muscle-on-a-Chip Price (US$/Unit) by Type (2021–2032)
Figure 56. Global Sales Market Share of Muscle-on-a-Chip by Application (2021–2032)
Figure 57. Global Revenue Market Share of Muscle-on-a-Chip by Application (2021–2032)
Figure 58. Global Muscle-on-a-Chip Price (US$/Unit) by Application (2021–2032)
Figure 59. Muscle-on-a-Chip Value Chain
Figure 60. Channels of Distribution (Direct Vs Distribution)
Figure 61. Bottom-up and Top-down Approaches for This Report
Figure 62. Data Triangulation
Figure 63. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What is the annual compound growth rate of the global Muscle-on-a-Chip market size from 2026 to 2032?
The annual compound growth rate of the global Muscle-on-a-Chip market is 26.1% 2026 to 2032.
What was the global market size of Muscle-on-a-Chip in 2032?
Which companies rank high in the global Muscle-on-a-Chip market?
What was the global market size of Muscle-on-a-Chip in 2026?
Which region is expected to have the highest market share?
Related Reports
Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-31
Pages: 167
USD 4900.00
(Single User License)
Global Muscle-on-a-Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published Date: 2026-03-31
Pages: 92
USD 4250.00
(Single User License)
Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published Date: 2026-01-19
Pages: 112
USD 3950.00
(Single User License)
Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-08-05
Pages: 166
USD 4900.00
(Single User License)
Global Muscle-on-a-Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-08-01
Pages: 92
USD 4250.00
(Single User License)
Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 126
USD 3950.00
(Single User License)
Global Muscle-on-a-Chip Market Research Report 2025
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published Date: 2025-03-10
Pages: 94
USD 2900.00
(Single User License)
Global Muscle-on-a-Chip Market Research Report 2024
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 97
USD 2900.00
(Single User License)
Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 113
USD 3950.00
(Single User License)
Global and United States Muscle-on-a-Chip Market Report & Forecast 2024-2030
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published Date: 2024-04-28
Pages: 122
USD 4350.00
(Single User License)
Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2032
The global Muscle-on-a-Chip market is projected to grow from US$ 359 million in 2025 to US$ 1784 million by 2032, at a CAGR of 26.1% (2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-31
Pages: 167
USD 4900.00 (Single User License)Global Muscle-on-a-Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global Muscle-on-a-Chip market size was US$ 359 million in 2025 and is forecast to reach a readjusted size of US$ 1784 million by 2032 with a CAGR of 26.1% during the forecast period 2026-2032.
Published: 2026-03-31
Pages: 92
USD 4250.00 (Single User License)Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for Muscle-on-a-Chip was estimated to be worth US$ 359 million in 2025 and is projected to reach US$ 1784 million, growing at a CAGR of 26.1% from 2026 to 2032.
Published: 2026-01-19
Pages: 112
USD 3950.00 (Single User License)Global Muscle-on-a-Chip Market Outlook, In‑Depth Analysis & Forecast to 2031
The global Muscle-on-a-Chip market is projected to grow from US$ 291 million in 2024 to US$ 1445 million by 2031, at a CAGR of 26.1% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-08-05
Pages: 166
USD 4900.00 (Single User License)Global Muscle-on-a-Chip Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global Muscle-on-a-Chip market size was US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-08-01
Pages: 92
USD 4250.00 (Single User License)Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for Muscle-on-a-Chip was estimated to be worth US$ 291 million in 2024 and is forecast to a readjusted size of US$ 1445 million by 2031 with a CAGR of 26.1% during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 126
USD 3950.00 (Single User License)Global Muscle-on-a-Chip Market Research Report 2025
The global market for Muscle-on-a-Chip was valued at US$ 291 million in the year 2024 and is projected to reach a revised size of US$ 1445 million by 2031, growing at a CAGR of 26.1% during the forecast period.
Published: 2025-03-10
Pages: 94
USD 2900.00 (Single User License)Global Muscle-on-a-Chip Market Research Report 2024
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 97
USD 2900.00 (Single User License)Muscle-on-a-Chip- Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 113
USD 3950.00 (Single User License)Global and United States Muscle-on-a-Chip Market Report & Forecast 2024-2030
Muscle-on-a-Chip is a biosimulation technology used to simulate the structure and function of human muscle tissue. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured muscle cells are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of real muscles, such as the contraction and movement function of muscle fibers. Muscle-on-a-Chip can be used to study the pathogenesis of muscle diseases, evaluate the efficacy and toxicity of drugs, and develop new treatments. This technology provides a highly controllable and reproducible experimental platform for muscle-related research, helping to advance the field of muscle medicine.
Published: 2024-04-28
Pages: 122
USD 4350.00 (Single User License)
CHOOSE LICENSE TYPE
USD 2900.00
USD 4350.00
USD 5800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now